Therapeutic Area Market Research Reports & Industry Analysis

The Therapeutic Area Market refers to a specific category of diseases or conditions for which there are known medical treatments or promising treatments in development. It is a way to classify drugs without reference to the type of therapy, form of action, or the company that makes it, but instead to look at the disease it treats.

Therapeutic areas include Cardiology/Vascular Diseases, Dental and Oral Health, Dermatology, Devices, Endocrinology, Family Medicine, Gastroenterology, Genetic Disease, Healthy Volunteers, Hematology, Hepatology, Immunology, Infections and Infectious Diseases, Internal Medicine, Musculoskeletal, Nephrology, Neurology, Nutrition and Weight Loss, Obstetrics/Gynecology, Oncology, Ophthalmology, Orthopedics/Orthopedic Surgery, Otolaryngology, Pediatrics/Neonatology, Pharmacology/Toxicology, Podiatry, Psychiatry/Psychology, Pulmonary/Respiratory Diseases, Rheumatology, Sleep, Trauma, Urology, and Vaccines.

Reports in these categories will contain statistics of prevalence and growth concerning therapeutic area diseases for which there are product reviews, market size, and share for products that are used in pharmaceutical treatment or equipment that used in surgical treatment of the therapeutic area.

...Show More ...Show Less


Therapeutic Area Industry Research & Market Reports

  • Human Reproductive Technologies

    ... by 2030, growing at a CAGR of 2.3% over the analysis period 2023-2030. Contraceptive Drugs & Devices, one of the segments analyzed in the report, is expected to record a 2.6% CAGR and reach US$22.0 ... Read More

  • Acute Heart Failure (AHF) Therapeutics

    ... is expected to reach US$2.9 Billion by 2030, growing at a CAGR of 21.3% over the analysis period 2023-2030. Cardiac Glycosides, one of the segments analyzed in the report, is expected to record a 21.8% ... Read More

  • Perfusion Systems

    ... at a CAGR of 4.3% over the analysis period 2023-2030. Cardiopulmonary Perfusion Systems, one of the segments analyzed in the report, is expected to record a 3.3% CAGR and reach US$671.0 Million by the end ... Read More

  • T-cell Lymphoma Market Size, Share & Trends Analysis Report By Type (Peripheral, Lymphoblastic), By Therapy (Radiotherapy, Immunotherapy, Stem Cell Transplantation), By Region, And Segment Forecasts, 2024 - 2030

    ... global T-cell lymphoma market size is anticipated to reach USD 3.70 billion by 2030, expanding at a CAGR of 8.83% from 2024 to 2030, according to a new report by Grand View Research, Inc. The ... Read More

  • Global Amniotic Membrane Market Report by Application (Ophthalmology, Surgical Wounds, Others) Product (Lyophilization Amniotic Membrane, Cryopreserved Amniotic Membrane) End User (Speciality Clinics, Hospital, Ambulatory Surgical Centers, Research & Academic Institutes) Countries and Company Analysis, 2024-2032

    ... Amniotic Membrane Market Analysis The Global Amniotic Membrane Market size will surpass US$ 6,588.2 Million by 2032 from US$ 2,437.7 Million in 2023, with a CAGR of 11.68% from 2024 to 2032. Some of the ... Read More

  • Bipolar Disorder Therapeutics

    ... by 2030, growing at a CAGR of 3.5% over the analysis period 2023-2030. Antipsychotic Drugs, one of the segments analyzed in the report, is expected to record a 3.3% CAGR and reach US$3.5 Billion by ... Read More

  • Orthopedic Medical Imaging Systems

    ... reach US$12.8 Billion by 2030, growing at a CAGR of 4.8% over the analysis period 2023-2030. X-ray Systems, one of the segments analyzed in the report, is expected to record a 4.2% CAGR and reach ... Read More

  • Cold, Cough, And Sore Throat Remedies

    ... the year 2023, is expected to reach US$9.7 Billion by 2030, growing at a CAGR of 5.2% over the analysis period 2023-2030. Syrups & Drops, one of the segments analyzed in the report, is expected ... Read More

  • Atrial Fibrillation Devices

    ... by 2030, growing at a CAGR of 12.2% over the analysis period 2023-2030. EP Ablation Catheters, one of the segments analyzed in the report, is expected to record a 14.6% CAGR and reach US$4.8 Billion ... Read More

  • Ophthalmology Picture Archiving and Communication Systems

    ... the year 2023, is expected to reach US$211.3 Million by 2030, growing at a CAGR of 6.2% over the analysis period 2023-2030. Integrated PACS, one of the segments analyzed in the report, is expected to ... Read More

  • Hormone Replacement Therapy (HRT)

    ... reach US$44.6 Billion by 2030, growing at a CAGR of 6.2% over the analysis period 2023-2030. Estrogen Hormone Replacement Therapy, one of the segments analyzed in the report, is expected to record a 6.3% CAGR ... Read More

  • Kidney Stone Management Devices

    ... reach US$2.3 Billion by 2030, growing at a CAGR of 4.8% over the analysis period 2023-2030. Ureteroscopy, one of the segments analyzed in the report, is expected to record a 5.4% CAGR and reach US$1.3 ... Read More

  • Infertility Treatment

    ... at a CAGR of 7.6% over the analysis period 2023-2030. Infertility Treatment Equipment, one of the segments analyzed in the report, is expected to record a 7.5% CAGR and reach US$1.3 Billion by the end ... Read More

  • Cancer Cachexia

    ... at a CAGR of 5.6% over the analysis period 2023-2030. Progestogens Therapeutics, one of the segments analyzed in the report, is expected to record a 5.8% CAGR and reach US$1.5 Billion by the end of ... Read More

  • Ophthalmic Lasers

    ... at a CAGR of 5.0% over the analysis period 2023-2030. Femtosecond Lasers, one of the segments analyzed in the report, is expected to record a 5.8% CAGR and reach US$757.4 Million by the end of ... Read More

  • Postpartum Hemorrhage (PPH) Treatment Devices

    ... is expected to reach US$1.1 Billion by 2030, growing at a CAGR of 4.6% over the analysis period 2023-2030. Uterine Balloon Tamponade, one of the segments analyzed in the report, is expected to record a ... Read More

  • Dry Age-related Macular Degeneration (Dry-AMD)- Pipeline Insight, 2024

    ... landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline ... Read More

  • Untreated Metastatic or Unresectable Melanoma- Pipeline Insight, 2024

    ... landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline ... Read More

  • Sex Toys

    ... at a CAGR of 7.8% over the analysis period 2023-2030. Adult Vibrators, one of the segments analyzed in the report, is expected to record a 8.3% CAGR and reach US$36.8 Billion by the end of ... Read More

  • Allergy Diagnostics

    ... at a CAGR of 10.2% over the analysis period 2023-2030. Allergy Diagnostics Assay Kits, one of the segments analyzed in the report, is expected to record a 10.9% CAGR and reach US$4.5 Billion by the ... Read More

  • Antidepressants

    ... of 2.5% over the analysis period 2023-2030. Antidepressants market for Major Depressive Disorder, one of the segments analyzed in the report, is expected to record a 2.2% CAGR and reach US$7.0 Billion by the end ... Read More

  • Smoking Cessation and Nicotine De-Addiction Products

    ... the year 2023, is expected to reach US$54.9 Billion by 2030, growing at a CAGR of 8.1% over the analysis period 2023-2030. E-cigarettes, one of the segments analyzed in the report, is expected to record ... Read More

  • Ophthalmic Pharmaceutical Drugs

    ... by 2030, growing at a CAGR of 3.7% over the analysis period 2023-2030. Anti-VEGF Agents Drug Class, one of the segments analyzed in the report, is expected to record a 4.5% CAGR and reach US$34.3 ... Read More

  • Cardiology IT Workflow Solutions

    ... reach US$1.8 Billion by 2030, growing at a CAGR of 8.0% over the analysis period 2023-2030. Cloud Deployment, one of the segments analyzed in the report, is expected to record a 9.0% CAGR and reach ... Read More

  • Optical Coherence Tomography (OCT) for Ophthalmology

    ... the year 2023, is expected to reach US$1.1 Billion by 2030, growing at a CAGR of 7.2% over the analysis period 2023-2030. Conventional OCT Systems, one of the segments analyzed in the report, is expected ... Read More

Cookie Settings